|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
CA2071867A1
(en)
|
1989-11-06 |
1991-05-07 |
Edith Mathiowitz |
Method for producing protein microspheres
|
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5804396A
(en)
|
1994-10-12 |
1998-09-08 |
Sugen, Inc. |
Assay for agents active in proliferative disorders
|
|
DE69536015D1
(de)
|
1995-03-30 |
2009-12-10 |
Pfizer Prod Inc |
Chinazolinone Derivate
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
GB9508565D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quiazoline derivative
|
|
GB9508537D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
WO1997007788A2
(en)
|
1995-08-31 |
1997-03-06 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
|
EA001595B1
(ru)
|
1996-04-12 |
2001-06-25 |
Варнер-Ламберт Компани |
Необратимые ингибиторы тирозинкиназ
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
ZA986732B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitiors of tyrosine kinases
|
|
ZA986729B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitors of tyrosine kinases
|
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
|
CA2532228C
(en)
|
2003-07-16 |
2017-02-14 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
|
WO2006029161A2
(en)
|
2004-09-07 |
2006-03-16 |
The Board Of Regents For Oklahoma State University |
Cell specific gene silencing using cell-specific promoters in vitro and in vivo
|
|
EP1937066A4
(en)
|
2005-08-18 |
2008-12-24 |
Alnylam Pharmaceuticals Inc |
METHOD AND COMPOSITIONS FOR THE TREATMENT OF NERVOUS DISEASES
|
|
AU2013203219B2
(en)
|
2005-11-02 |
2016-09-22 |
Arbutus Biopharma Corporation |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
|
CN101346393B
(zh)
|
2005-11-02 |
2015-07-22 |
普洛体维生物治疗公司 |
修饰的siRNA分子及其应用
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
US20070258952A1
(en)
|
2006-05-04 |
2007-11-08 |
Baylor Research Institute |
Anti-Tumor Activity of an Oncolytic Adenovirus-Delivered Oncogene siRNA
|
|
US20080039415A1
(en)
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
|
CA2675954A1
(en)
|
2007-01-18 |
2008-07-24 |
Plant Bioscience Limited (Pbl) |
Methods and compositions for modulating the mirna pathway
|
|
WO2009082606A2
(en)
|
2007-12-04 |
2009-07-02 |
Alnylam Pharmaceuticals, Inc. |
Folate conjugates
|
|
WO2009104051A2
(en)
|
2007-12-31 |
2009-08-27 |
Lu Patrick Y |
Combinational therapeutics for treatment of prostate cancer using epoxy encapsulated magnetic particles and rnai medicine
|
|
US20110130440A1
(en)
|
2008-03-26 |
2011-06-02 |
Alnylam Pharmaceuticals, Inc. |
Non-natural ribonucleotides, and methods of use thereof
|
|
CA2721183C
(en)
|
2008-04-11 |
2019-07-16 |
Alnylam Pharmaceuticals, Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
EP2321414B1
(en)
|
2008-07-25 |
2018-01-10 |
Alnylam Pharmaceuticals, Inc. |
Enhancement of sirna silencing activity using universal bases or mismatches in the sense strand
|
|
AU2009298802A1
(en)
|
2008-09-23 |
2010-04-08 |
Alnylam Pharmaceuticals, Inc. |
Chemical modifications of monomers and oligonucleotides with cycloaddition
|
|
WO2010078517A2
(en)
|
2008-12-31 |
2010-07-08 |
Sirnaomics, Inc. |
Compositions and methods using sirna molecules and sirna cocktails for the treatment of breast cancer
|
|
CA3045126A1
(en)
|
2009-05-05 |
2010-11-11 |
Arbutus Biopharma Corporation |
Methods of delivering oligonucleotides to immune cells
|
|
CN102753187A
(zh)
|
2009-06-03 |
2012-10-24 |
戴瑟纳制药公司 |
肽-dicer底物试剂及其特异性抑制基因表达的方法
|
|
US8957038B2
(en)
|
2009-07-15 |
2015-02-17 |
Medtronic, Inc. |
Treatment of neurological disorders
|
|
AU2010324658A1
(en)
|
2009-11-26 |
2012-05-03 |
Quark Pharmaceuticals, Inc. |
siRNA compounds comprising terminal substitutions
|
|
EP3318248B1
(en)
|
2009-12-01 |
2019-04-10 |
Translate Bio, Inc. |
Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
|
|
EP3296398A1
(en)
|
2009-12-07 |
2018-03-21 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
|
WO2011072292A2
(en)
|
2009-12-11 |
2011-06-16 |
Dicerna Pharmaceuticals, Inc. |
Phase changing formulations of rna and rna derivatives
|
|
WO2011097480A1
(en)
|
2010-02-05 |
2011-08-11 |
University Of Louisville Research Foundation, Inc. |
Exosomal compositions and methods for the treatment of disease
|
|
WO2011133707A2
(en)
|
2010-04-23 |
2011-10-27 |
Kineta, Inc. |
Anti-viral compounds
|
|
US20130123338A1
(en)
|
2010-05-12 |
2013-05-16 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
WO2013048734A1
(en)
|
2011-09-28 |
2013-04-04 |
Tufts Medical Center, Inc. |
Treatment and prevention of cardiovascular disease with cell derived lipid vesicles, microvesicles and exosomes
|
|
EP2725103A3
(en)
|
2011-11-14 |
2016-01-06 |
Silenseed Ltd |
Methods and compositions for treating prostate cancer
|
|
WO2013103467A1
(en)
|
2012-01-06 |
2013-07-11 |
Alcon Research, Ltd. |
Interfering rna delivery system and uses thereof
|
|
EP2817287B1
(en)
|
2012-02-24 |
2018-10-03 |
Arbutus Biopharma Corporation |
Trialkyl cationic lipids and methods of use thereof
|
|
EA201590197A1
(ru)
|
2012-08-23 |
2015-07-30 |
Алиос Биофарма, Инк. |
Соединения для лечения парамиксовирусных вирусных инфекций
|
|
KR102396026B1
(ko)
|
2014-01-21 |
2022-05-09 |
안자리움 바이오사이언시스 아게 |
하이브리도좀, 이를 포함하는 조성물, 이의 제조 방법 및 이의 용도
|
|
WO2016057693A1
(en)
|
2014-10-10 |
2016-04-14 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
|
WO2016069740A1
(en)
*
|
2014-10-29 |
2016-05-06 |
The Regents Of The University Of California |
Bioactive delivery vehicles
|
|
CA3017586A1
(en)
*
|
2016-03-15 |
2017-09-21 |
Codiak Biosciences, Inc. |
Therapeutic membrane vesicles
|
|
GB201609216D0
(en)
|
2016-05-25 |
2016-07-06 |
Evox Therapeutics And Isis Innovation Ltd |
Exosomes comprising therapeutic polypeptides
|
|
GB2552301A
(en)
|
2016-07-11 |
2018-01-24 |
Evox Therapeutics Ltd |
Metabolic drug loading of EVs
|
|
GB2552460A
(en)
|
2016-07-11 |
2018-01-31 |
Evox Therapeutics Ltd |
CPP-Mediated EV Loading
|
|
CA3043768A1
(en)
|
2016-11-29 |
2018-06-07 |
PureTech Health LLC |
Exosomes for delivery of therapeutic agents
|
|
WO2019018349A1
(en)
|
2017-07-17 |
2019-01-24 |
Codiak Biosciences, Inc. |
NANOVESICLES PRODUCED FROM MESENCHYMAL STROMAL CELLS FOR ANTI-INFLAMMATORY APPLICATIONS
|
|
IL272786B2
(en)
|
2017-08-25 |
2025-03-01 |
Codiak Biosciences Inc |
Preparation of therapeutic exosomes using membrane proteins
|
|
GB201717446D0
(en)
|
2017-10-24 |
2017-12-06 |
Evox Therapeutics Ltd |
Affinity purification of engineering extracellular vesicles
|
|
GB2568255A
(en)
|
2017-11-08 |
2019-05-15 |
Evox Therapeutics Ltd |
Exosomes comprising RNA therapeutics
|
|
GB201718681D0
(en)
|
2017-11-13 |
2017-12-27 |
Evox Therapeutics Ltd |
Protein engineered extracellular vesicles
|
|
US20190175506A1
(en)
|
2017-11-17 |
2019-06-13 |
Codiak Biosciences, Inc. |
Loading of Extracellular Vesicles through Imparting of Mechanical Shear
|
|
CN111655271B
(zh)
|
2017-12-28 |
2025-09-23 |
隆萨销售股份公司 |
用于免疫肿瘤学和抗炎疗法的外来体
|
|
GB201802163D0
(en)
|
2018-02-09 |
2018-03-28 |
Evox Therapeutics Ltd |
Compositions for EV storage and formulation
|
|
MX2020011570A
(es)
|
2018-05-07 |
2020-11-24 |
Alnylam Pharmaceuticals Inc |
Administracion extrahepatica.
|
|
GB201809622D0
(en)
|
2018-06-12 |
2018-07-25 |
Evox Therapeutics Ltd |
Engineering extracellular vesicles for affinity purification
|
|
GB201810301D0
(en)
|
2018-06-22 |
2018-08-08 |
Evox Therapeutics Ltd |
Combinatorial gene therapy
|
|
WO2020035620A1
(en)
|
2018-08-17 |
2020-02-20 |
Centre National De La Recherche Scientifique (Cnrs) |
Rna-based therapeutic methods to protect animals against pathogenic bacteria and / or promote beneficial effects of symbiotic and commensal bacteria
|
|
EP3841112A1
(en)
|
2018-08-24 |
2021-06-30 |
Codiak BioSciences, Inc. |
Extracellular vesicles targeting dendritic cells and uses thereof
|
|
KR20210105889A
(ko)
|
2018-11-09 |
2021-08-27 |
아뷰터스 바이오파마 코포레이션 |
지질 나노입자 제제
|
|
CN113272426A
(zh)
|
2018-11-16 |
2021-08-17 |
医福斯治疗有限公司 |
用于尿素循环蛋白和核酸的替代的细胞外囊泡
|
|
WO2020123083A1
(en)
|
2018-12-12 |
2020-06-18 |
Dicerna Pharmaceuticals, Inc. |
Double-stranded nucleic acid inhibitor molecules containing a triloop
|
|
CN110699382A
(zh)
|
2019-11-08 |
2020-01-17 |
赵凯 |
一种递送siRNA的外泌体的制备方法
|
|
IT201900024580A1
(it)
*
|
2019-12-18 |
2021-06-18 |
Consiglio Nazionale Ricerche |
Vescicole extracellulari da microalghe
|
|
EP3967745A1
(en)
*
|
2020-09-11 |
2022-03-16 |
Immunrise |
Chlorella-based production of extracellular vesicle-embedded small rnas for biocontrol applications
|
|
EP3967746A1
(en)
*
|
2020-09-11 |
2022-03-16 |
Immunrise |
Chlorella-based production of extracellular vesicle-embedded small rnas for prophylactic or therapeutic applications
|